- About
- Advertise
- CureToday.com
- OncLive.com
- OncNursingNews.com
- TargetedOnc.com
- Contact
- Terms and Conditions
- Privacy
- Do Not Sell My Personal Information
© 2023 MJH Life Sciences™ and Cancer Network. All rights reserved.
Adam J. Gadzinski, MD, MS | Authors
Adam J. Gadzinski, MD, MS, on Up-and-Coming Research for Urologic Oncology
January 07, 2021
The expert in urologic oncology spoke about new innovations that he believes will aid in treating patients with urologic cancers.
Adam J. Gadzinski, MD, MS, on Next Steps for Assessing the Impact of Telemedicine on Patient-Reported Outcomes
January 03, 2021
An expert in urologic oncology seeks to answer further questions regarding the use of telemedicine for this patient population.
Adam J. Gadzinski, MD, MS, on the Limitations of a Study Assessing the Impact of Telemedicine on Patient-Reported Outcomes
December 28, 2020
Study results revealed the impact of a rurally focused telemedicine program on patient outcomes.
Adam J. Gadzinski, MD, MS, on Study Results Assessing the Impact of Telemedicine on Patient-Reported Outcomes
December 21, 2020
The study was designed to determine the impact of a rurally focused telemedicine program on patient outcomes.
Adam J. Gadzinksi, MD, MS, on the Impact of Telemedicine on Patient-Reported Outcomes
December 09, 2020
The study assessed the impact of a rurally focused telemedicine program on patient outcomes in the urologic oncology outpatient clinic at the University of Washington Medical Center.
Adam J. Gadzinski, MD, MS, on the Design of a Study Assessing Impact of Telemedicine on Patient-Reported Outcomes
December 07, 2020
The study sought to determine the impact of a rurally focused telemedicine program on patient outcomes.
Adam J. Gadzinski, MD, MS, on the Research Coming Out of SUO This Year
December 05, 2020
Gadzinski spoke about the most exciting aspect of the research coming out of the 21st Annual Meeting of the Society of Urologic Oncology (SUO).